177lu-dota-tate,triapine
novartis
['lu 177', 'lutetium lu 177 dotatate', 'triapine', 'pancreatic']
#aacr23 poster w/ drs. for #etctn (10388): first in human phase i trial of triapine and lutetium lu 177 dotatate in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (gep-nets). 
Official Twitter account of NCI's Cancer Therapy Evaluation Program, providing updates to our trials research community. Part of @NIH. Privacy: https://t.co/9Aox3geiD8